Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time
DOI10.1111/J.1541-0420.2011.01646.XzbMath1241.62146OpenAlexW2011778653WikidataQ35556037 ScholiaQ35556037MaRDI QIDQ2894011
Daniel J. Sargent, Marc Buyse, Tomasz Burzykowski, Stuart G. Baker
Publication date: 27 June 2012
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3218246
Applications of statistics to biology and medical sciences; meta analysis (62P10) Censored data models (62N01) Estimation in survival analysis and censored data (62N02)
Uses Software
Cites Work
- Unnamed Item
- Exploring and validating surrogate endpoints in colorectal cancer
- Principal Stratification in Causal Inference
- Identification of Causal Effects Using Instrumental Variables
- Identification and Estimation of Local Average Treatment Effects
- The validation of surrogate endpoints in meta-analyses of randomized experiments
- On meta-analytic assessment of surrogate outcomes
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
- Simultaneous-Equation Estimation in a Clinical Trial of the Effect of Smoking on Birth Weight
This page was built for publication: Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time